BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37094365)

  • 1. Dynamics of overdose and non-overdose mortality among people living with HIV amidst the illicit drug toxicity crisis in British Columbia.
    Yazdani K; Dhillon N; Tung A; Ye M; Trigg J; Stanley C; Ni Gusti Ayu N; McLinden T; Lima VD; Barrios R; Hogg R; Montaner JSG; Salters K
    AIDS Care; 2024 Feb; 36(2):263-271. PubMed ID: 37094365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription-related risk factors for opioid-related overdoses in the era of fentanyl contamination of illicit drug supply: A retrospective case-control study.
    Smolina K; Crabtree A; Chong M; Park M; Mill C; Zhao B; Schütz CG
    Subst Abus; 2022; 43(1):92-98. PubMed ID: 32441588
    [No Abstract]   [Full Text] [Related]  

  • 4. The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada.
    Salters KA; Parent S; Nicholson V; Wang L; Sereda P; Pakhomova TE; Kibel M; Chau W; Closson K; Parashar S; Barrios R; Montaner JSG; Hogg RS
    BMC Public Health; 2021 Apr; 21(1):680. PubMed ID: 33832472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.
    St-Jean M; Dong X; Tafessu H; Moore D; Honer WG; Vila-Rodriguez F; Sereda P; Hogg RS; Patterson TL; Salters K; Barrios R; Montaner JSG; Lima VD
    Int J Drug Policy; 2021 Oct; 96():103195. PubMed ID: 33773878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the socioeconomic profile of people who experienced opioid overdoses in British Columbia, 2014 to 2016.
    Carrière G; Garner R; Sanmartin C
    Health Rep; 2021 Feb; 32(2):27-38. PubMed ID: 33595226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
    Foreman-Mackey A; Xavier J; Corser J; Fleury M; Lock K; Mehta A; Lamb J; McDougall J; Newman C; Buxton JA
    BMC Public Health; 2023 Apr; 23(1):640. PubMed ID: 37013524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
    Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.
    Parent S; Nolan S; Fairbairn N; Ye M; Wu A; Montaner J; Barrios R; Ti L;
    Int J Drug Policy; 2019 May; 67():52-57. PubMed ID: 30897373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada.
    Clark J; Fairbairn N; Nolan S; Li T; Wu A; Barrios R; Montaner J; Ti L;
    AIDS Behav; 2019 Dec; 23(12):3331-3339. PubMed ID: 31286318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characteristics of the Provincial Overdose Cohort in British Columbia, Canada.
    MacDougall L; Smolina K; Otterstatter M; Zhao B; Chong M; Godfrey D; Mussavi-Rizi A; Sutherland J; Kuo M; Kendall P
    PLoS One; 2019; 14(1):e0210129. PubMed ID: 30629607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using linked data to identify pathways of reporting overdose events in British Columbia, 2015-2017.
    Graham E; Zhao B; Flynn M; Gustafson P; Irvine MA; Slaunwhite A; Orpana H; Kuo M; MacDougall L
    Int J Popul Data Sci; 2022; 7(1):1708. PubMed ID: 37650030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of Safe Supply Alternatives During Intersecting COVID-19 and Overdose Health Emergencies in British Columbia, Canada, 2021.
    McNeil R; Fleming T; Mayer S; Barker A; Mansoor M; Betsos A; Austin T; Parusel S; Ivsins A; Boyd J
    Am J Public Health; 2022 Apr; 112(S2):S151-S158. PubMed ID: 35262376
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis.
    Milloy MJ; Wood E; Reading C; Kane D; Montaner J; Kerr T
    Addiction; 2010 Nov; 105(11):1962-70. PubMed ID: 20825372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative changes in illicit drug supply during COVID-19: Associations with use of overdose prevention and health services among women sex workers who use drugs (2020-2021).
    Moreheart S; Shannon K; Krüsi A; McDermid J; Ettinger E; Braschel M; Goldenberg SM
    Int J Drug Policy; 2023 Nov; 121():104212. PubMed ID: 37797570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis.
    Lee Y; Lui LMW; Brietzke E; Liao Y; Lu C; Ho R; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    J Affect Disord; 2022 Jan; 296():514-521. PubMed ID: 34656039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.